Content - Diagnosed with lympoma

Successful public event on the subject of lymphomas

What are the current treatment standards for lymphomas? What are the advantages and disadvantages of different therapies? How does stem cell therapy work for lymphoma patients?

These and many other topics were presented and being discussed on Thursday, 23 November 2017. This public event was once more held by the SAKK patient advisory board and, like their first event on breast cancer in June, was met with great interest: Over 50 visitors, among them many patients and their relatives, attended at the Marriott Hotel in Zurich.

After a brief introduction of SAKK and the role of the SAKK patient advisory board by Dr. Peter Durrer, Prof. Dr. med. Christoph Renner (Onkozentrum Zurich) opened the event with his presentation «Neue Medikamente in der Lymphombehandlung» (new medications to treat lymphoma). Prof. Renner particularly emphasized the effects, opportunities and risks of immunotherapy. His conclusion: new drugs are more targeted and can maybe heal more patients, but they also have different side effects – and are expensive. Since the second expert speaker, PD Dr. med. Urs Schanz (University Hospital Zurich) was absent due to illness, Prof. Renner held a second presentation on high-dose chemotherapy and stem cell transplant for lymphoma («Hochdosis-Chemotherapie und Stammzell-Transplantation – neue Ansätze»). He elaborated on the different types of stem cell transplants and weighed in on how intensive chemotherapy should/may be.

PD Dr. med. Urban Novak (Inselspital Bern) subsequently introduced standards and trends in clinical research («Klinische Forschung – Aktuelles und Zukünftiges»). He emphasized the many different types of lymphoma and their respective challenges. Rosmarie Pfau from the SAKK patient advisory board and President of ho/noho – concluded the event with her talk «Langzeitfolgen und Lebensqualität» (long-term effects and quality of life) and pointed out the vital role of patient organizations in consulting patients.

Between presentations and during the following reception, the experts took their time to answer questions of patients and their relatives and managed to impart the difficult subjects in a comprehensible manner.